{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T08:39:29Z","timestamp":1776760769298,"version":"3.51.2"},"reference-count":70,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.cld.2023.07.010","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T15:30:14Z","timestamp":1693236614000},"page":"183-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cholangiocarcinoma Surveillance Recommendations in Patients with Primary Sclerosing Cholangitis"],"prefix":"10.1016","volume":"28","author":[{"given":"Daniel","family":"Saca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven L.","family":"Flamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cld.2023.07.010_bib1","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis \u2013 a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2023.07.010_bib2","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/MEG.0b013e3283554bbf","article-title":"Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience","volume":"24","author":"Chapman","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2023.07.010_bib3","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"issue":"4\u20135","key":"10.1016\/j.cld.2023.07.010_bib4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.autrev.2014.01.028","article-title":"Diagnosis and classification of ulcerative colitis","volume":"13","author":"Conrad","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.cld.2023.07.010_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12328-011-0282-1","article-title":"Hepatopancreatobiliary manifestations of inflammatory bowel disease","volume":"5","author":"Nakamura","year":"2012","journal-title":"Clinical Journal of Gastroenterology"},{"issue":"4\u20135","key":"10.1016\/j.cld.2023.07.010_bib6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.autrev.2014.01.040","article-title":"Diagnosis and classification of primary sclerosing cholangitis","volume":"13","author":"Yimam","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.cld.2023.07.010_bib7","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weismuller","year":"2017","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2023.07.010_bib8","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broome","year":"1996","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.cld.2023.07.010_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MOG.0000000000000333","article-title":"The evolution of natural history of primary sclerosing cholangitis","volume":"33","author":"Takakura","year":"2017","journal-title":"Curr Opin Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2023.07.010_bib10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","article-title":"Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis","volume":"99","author":"Burak","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2023.07.010_bib11","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1478-3231.2011.02575.x","article-title":"Malignancies and mortality in 200 patients with primary sclerosering cholangitis: a long-term single-centre study","volume":"32","author":"Fevery","year":"2012","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.cld.2023.07.010_bib12","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/liv.13328","article-title":"Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort","volume":"37","author":"Liu","year":"2017","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.cld.2023.07.010_bib13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1478-3231.2011.02614.x","article-title":"Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort","volume":"32","author":"de Valle","year":"2012","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.cld.2023.07.010_bib14","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/hep.24743","article-title":"Mortality and the risk of malignancy in autoimmune liver diseases: a population-based study in Canterbury, New Zealand","volume":"55","author":"Ngu","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.07.010_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/j.1572-0241.2004.04067.x","article-title":"Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangigis","author":"Burak","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.cld.2023.07.010_bib16","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/003655202760373434","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation","volume":"37","author":"Boberg","year":"2002","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2023.07.010_bib17","first-page":"45","article-title":"A\u00a0review of the challenges associated with the diagnosis and therapy of primary sclerosing cholangitis","volume":"2","author":"Saadi","year":"2014","journal-title":"Journal of Clinical and Translational Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2023.07.010_bib18","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ajg.2015.112","article-title":"ACG clinical guideline: primary sclerosing cholangitis","volume":"110","author":"Lindor","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2023.07.010_bib19","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000440823","article-title":"Diagnosis, differential diagnosis, and epidemiology of primary sclerosing cholangitis","volume":"33","author":"Ponsioen","year":"2015","journal-title":"Dig Dis"},{"issue":"1","key":"10.1016\/j.cld.2023.07.010_bib20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000347206","article-title":"Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics","volume":"31","author":"Ehlken","year":"2013","journal-title":"Dig Dis"},{"issue":"5","key":"10.1016\/j.cld.2023.07.010_bib21","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1055\/s-0041-110792","article-title":"Screening primary sclerosing cholangitis and biliary dysplasia with endoscopic retrograde cholangiography and brush cytology: risk factors for biliary neoplasia","volume":"48","author":"Boyd","year":"2016","journal-title":"Endoscopy"},{"key":"10.1016\/j.cld.2023.07.010_bib22","article-title":"Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma","author":"Chung","year":"2017","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.cld.2023.07.010_bib23","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0168-8278(00)00034-9","article-title":"Biliary dysplasia as a marker of cholangiocarcinoma in primary sclerosing cholangitis","volume":"34","author":"Zarski","year":"2001","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2023.07.010_bib24","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1136\/gutjnl-2016-313598","article-title":"Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis","volume":"67","author":"Alberts","year":"2018","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.cld.2023.07.010_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-0037-1603324","article-title":"Epigenetics in the primary biliary cholangitis and primary sclerosing cholangitis","volume":"37","author":"Cheung","year":"2017","journal-title":"Semin Liver Dis"},{"issue":"1","key":"10.1016\/j.cld.2023.07.010_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.728","article-title":"Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci","volume":"43","author":"Melum","year":"2011","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.cld.2023.07.010_bib27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jhep.2009.01.023","article-title":"Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis","volume":"51","author":"Rudolph","year":"2009","journal-title":"Journal of hepatology"},{"issue":"6","key":"10.1016\/j.cld.2023.07.010_bib28","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1055\/s-0043-107029","article-title":"Role of endoscopy in primary sclerosing cholangitis: European society of gastrointestinal endoscopy (ESGE) and European association for the study of the liver (EASL) clinical guideline","volume":"49","author":"Aabakken","year":"2017","journal-title":"Endoscopy"},{"issue":"2","key":"10.1016\/j.cld.2023.07.010_bib29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000128169","article-title":"Cholangiocarcinoma complicating primary sclerosing cholangitis: a 24-year experience","volume":"25","author":"Morris-Stiff","year":"2008","journal-title":"Dig Surg"},{"issue":"6","key":"10.1016\/j.cld.2023.07.010_bib30","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","article-title":"Pathogenesis, diagnosis, and management of cholangiocarcinoma","volume":"145","author":"Rizvi","year":"2013","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2023.07.010_bib31","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/MOG.0b013e328337b311","article-title":"An update on cholangiocarcinoma associated with primary sclerosing cholangitis","volume":"26","author":"Fevery","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2023.07.010_bib32","first-page":"1","article-title":"Greater biosynthetic liver dysfunction in primary sclerosing cholangitis suggests co-existent or impending cholangiocarcinoma","volume":"4","author":"Trilianos","year":"2016","journal-title":"Journal of Clinical and Translational Hepatology"},{"issue":"12","key":"10.1016\/j.cld.2023.07.010_bib33","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.cgh.2015.05.035","article-title":"Primary sclerosing cholangitis as a premalignant biliary tract disease: surveillance and management","volume":"13","author":"Rizvi","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2023.07.010_bib34","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/hep.24247","article-title":"Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"53","author":"Molodecky","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.07.010_bib35","doi-asserted-by":"crossref","DOI":"10.1186\/1471-230X-11-83","article-title":"The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population","volume":"11","author":"Toy","year":"2011","journal-title":"BMC Gastroenterol"},{"issue":"7","key":"10.1016\/j.cld.2023.07.010_bib36","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1432-2277.2010.01108.x","article-title":"Liver transplantation for cholangiocarcinoma","volume":"23","author":"Rosen","year":"2010","journal-title":"Transpl Int"},{"issue":"4","key":"10.1016\/j.cld.2023.07.010_bib37","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.22441","article-title":"Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis","volume":"48","author":"Charatcharoenwitthaya","year":"2008","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2023.07.010_bib38","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/hep.28744","article-title":"Liver transplantation for \u201cvery early\u201d intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment","volume":"64","author":"Sapisochin","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.07.010_bib39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejso.2018.09.008","article-title":"Clinical outcome after resection of early-stage hilar cholangiocarcinoma","volume":"45","author":"Stremitzer","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.cld.2023.07.010_bib40","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/00365521.2016.1250281","article-title":"Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma","volume":"52","author":"Boyd","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cld.2023.07.010_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(18)30365-9","article-title":"Serum metabolites as diagnostic biomarkers for cholangiocarcinoma, hepatocellular carcinoma and primary sclerosing cholangitis","author":"Banales","year":"2018","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.cld.2023.07.010_bib42","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1007\/s00261-017-1328-8","article-title":"Cholangiocarcinoma and its mimickers in primary sclerosing cholangitis","volume":"42","author":"Lee","year":"2017","journal-title":"Abdominal Radiology"},{"key":"10.1016\/j.cld.2023.07.010_bib43","article-title":"Recent developments in the research on biomarkers of cholangiocarcinoma in primary sclerosing cholangitis","author":"Wannhoff","year":"2018","journal-title":"Clinics and Research in Hepatology and Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2023.07.010_bib44","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.cgh.2011.02.007","article-title":"Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma","volume":"9","author":"Sinakos","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2023.07.010_bib45","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jhep.2013.08.005","article-title":"FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"59","author":"Wannhoff","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2023.07.010_bib46","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1007\/s10620-005-2927-8","article-title":"The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis","volume":"50","author":"Levy","year":"2005","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.cld.2023.07.010_bib47","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/17474124.2018.1473761","article-title":"Diagnosis of cholangiocarcinoma in primary sclerosing cholangitis","volume":"12","author":"Taghavi","year":"2018","journal-title":"Expet Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2023.07.010_bib48","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s10620-016-4370-4","article-title":"Carcinoembryonic antigen level in primary sclerosing cholangitis is not influenced by dominant strictures or bacterial cholangitis","volume":"62","author":"Wannhoff","year":"2017","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.cld.2023.07.010_bib49","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/hep.29730","article-title":"Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis","volume":"67","author":"Ali","year":"2018","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2023.07.010_bib50","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/hep.29293","article-title":"Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the International PSC Study Group","volume":"66","author":"Schramm","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2023.07.010_bib51","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12029-015-9777-1","article-title":"The detection of cholangiocarcinoma in primary sclerosing cholangitis patients: single center experience","volume":"47","author":"Kuzu","year":"2016","journal-title":"J\u00a0Gastrointest Cancer"},{"issue":"1","key":"10.1016\/j.cld.2023.07.010_bib52","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.gie.2014.09.017","article-title":"Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: a systematic review and meta-analysis","volume":"81","author":"Navaneethan","year":"2015","journal-title":"Gastrointest Endosc"},{"issue":"5","key":"10.1016\/j.cld.2023.07.010_bib53","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.gie.2013.09.015","article-title":"Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"79","author":"Trikudanathan","year":"2014","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"10.1016\/j.cld.2023.07.010_bib54","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/1756283X14564674","article-title":"Triple modality testing by endoscopic retrograde cholangiopancreatography for the diagnosis of cholangiocarcinoma","volume":"8","author":"Nanda","year":"2015","journal-title":"Therapeutic advances in gastroenterology"},{"key":"10.1016\/j.cld.2023.07.010_bib55","unstructured":"Levy MJ, Baron TH, Clayton AC, Enders FB, Gostout CJ, Halling KC, Kipp BR, Petersen BT, Roberts LR, Rumalla A, Sebo TJ, Clinic Rev Allerg Immunol (2020) 58:134\u2013149 147."},{"issue":"5","key":"10.1016\/j.cld.2023.07.010_bib56","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1572-0241.2007.01776.x","article-title":"Prospective evaluation of advanced molecular markers and imaging techniques in patients with indeterminate bile duct strictures","volume":"103","author":"Topazian","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2023.07.010_bib57","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1053\/j.gastro.2006.08.021","article-title":"Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures","volume":"131","author":"Moreno Luna","year":"2006","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2023.07.010_bib58","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/00365521.2016.1263681","article-title":"Clinical implications of serial versus isolated biliary fluorescence in\u00a0situ hybridization (FISH) polysomy in primary sclerosing cholangitis","volume":"52","author":"Quinn","year":"2017","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2023.07.010_bib59","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/jgh.13824","article-title":"Role of fluorescence in\u00a0situ hybridization in diagnosing cholangiocarcinoma in indeterminate biliary strictures","volume":"33","author":"Liew","year":"2018","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2023.07.010_bib60","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-0038-1655775","article-title":"Emerging technologies for the diagnosis of perihilar cholangiocarcinoma","volume":"38","author":"Rizvi","year":"2018","journal-title":"Semin Liver Dis"},{"issue":"3","key":"10.1016\/j.cld.2023.07.010_bib61","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s10620-018-4906-x","article-title":"Role of fluorescent in\u00a0situ hybridization, cholangioscopic biopsies, and EUS-FNA in the evaluation of biliary strictures","volume":"63","author":"Brooks","year":"2018","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.cld.2023.07.010_bib62","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1477-2574.2011.00298.x","article-title":"Transperitoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination","volume":"13","author":"Heimbach","year":"2011","journal-title":"HPB: The Official Journal of the International Hepato Pancreato Biliary Association"},{"issue":"2","key":"10.1016\/j.cld.2023.07.010_bib63","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2023.07.010_bib64","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/apt.13516","article-title":"Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD","volume":"43","author":"Fevery","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.cld.2023.07.010_bib65","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.crohns.2011.07.015","article-title":"A\u00a0unique clinical phenotype of primary sclerosing cholangitis associated with Crohn's disease","volume":"6","author":"Halliday","year":"2012","journal-title":"Journal of Crohn's & Colitis"},{"key":"10.1016\/j.cld.2023.07.010_bib66","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s12016-019-08764-7","article-title":"Cholangiocarcinoma in patients with primary sclerosing cholangitis (PSC); a comprehensive review","volume":"58","author":"Song","year":"2020","journal-title":"Clin Rev Allerg Immunol"},{"issue":"2","key":"10.1016\/j.cld.2023.07.010_bib67","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.32771","article-title":"AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma","volume":"77","author":"Bowlus","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2023.07.010_bib68","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"Easl clinical practice guidelines on sclerosing cholangitis","volume":"77","author":"Chazouilleres","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2023.07.010_bib69","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/gutjnl-2018-317993","article-title":"British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis","volume":"68","author":"Chapman","year":"2019","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.cld.2023.07.010_bib70","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/liv.13354","article-title":"An update on cancer risk and surveillance in primary sclerosing cholangitis","volume":"37","author":"Horsley-Silva","year":"2017","journal-title":"Liver Int"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326123000909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326123000909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:00:09Z","timestamp":1761069609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326123000909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1089326123000909"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2023.07.010","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholangiocarcinoma Surveillance Recommendations in Patients with Primary Sclerosing Cholangitis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2023.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}